FORT LAUDERDALE, FL / ACCESS Newswire / February 18, 2025 / ZEO ScientifiX, Inc. ("ZEO" or the "Company") (OTCQB:ZEOX), a clinical-stage biopharmaceutical company focused on the research and development of innovative biological therapeutics for the treatment of degenerative diseases and regenerative medicine and the development and sales of biologic products used in topical aesthetic applications, […]

NEW YORK, NY / ACCESS Newswire / February 18, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of ePlus inc. ("ePlus inc.") (NASDAQ:PLUS) concerning possible violations of federal securities laws. ePlus announced on February 5, 2025, its results of operations for its three and nine months ended December 31, 2024,

NEW YORK, NY / ACCESS Newswire / February 18, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Agilysys, Inc. ("Agilysys, Inc.") (NASDAQ:AGYS) concerning possible violations of federal securities laws. On January 21, 2025, Agilysys issued a press release announcing third quarter revenue below expectations and the company’s own guidance,

NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your Transocean Ltd. (NYSE:RIG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transocean-ltd-lawsuit-submission-form?prid=130168&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your Venture Global, Inc. (NYSE:VG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/venture-global-inc-lawsuit-submission-form?prid=130165&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

(NYSE:FCN), WASHINGTON, Feb. 18, 2025 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the appointments of Emily Golenberg and Mitali Sharma as Senior Managing Directors in the Transactions practice within the firm's Corporate Finance & Restructuring segment. Ms. Golenberg and Ms. Sharma bring a wealth of experience in supporting businesses throughout the entire

https://mma.prnewswire.com/media/2620764/Perimeter_Medical_Imaging_AI_Inc__CHRISTUS_St__Vincent_First_in.jpg Perimeter Medical Imaging AI announced today that CHRISTUS St. Vincent is the first hospital in New Mexico to use the company's S-Series OCT (Optical Coherence Tomography) technology to visualize tissue margins in the operating room. CHRISTUS St. Vincent offers the only Commission on Cancer (CoC) accredited breast cancer program in northern New Mexico. “This

Carnival Corporation & plc (NYSE/LSE: CCL; NYSE: CUK) today announced that Carnival Corporation (the “Company”) commenced a private offering (the “Notes Offering”) of new senior unsecured notes in an aggregate principal amount of $1.0 billion, expected to mature in 2030 (the “Notes”), to refinance the Company's $1.0 billion 10.500% senior unsecured notes due 2030 (the

Funding to drive investments into securities in Emerging Markets, including Saudi Arabia, Greece, Vietnam, Mexico, Indonesia, and the Philippines. Fiera Capital Corporation (“Fiera Capital”) is pleased to announce a $100 million USD seed investment into the Oaks EM Select strategy (the “Strategy”) in the U.S. in a privately offered fund sponsored and advised by Fiera

Vibativ® is a life-saving antibiotic for pneumonia and serious skin infections Approval in China paves the way for launch in world's second-largest market Specialty pharmaceutical companies Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) and SciClone Pharmaceuticals (Holdings) Limited (“SciClone Pharmaceuticals” or “SciClone”) today announced the NMPA (National Medical Products Administration) approval of Cumberland's Vibativ® (telavancin) injection in